The role of gefitinib in Asian nonsmokers with lung cancer
September 15th, 2008
Debi wrote an interesting post today on
Here’s a quick excerpt
The targeted therapy gefitinib should be considered a first-line therapy for non-smoking Asian patients with adenocarcinoma of the lung, one of the most common types of lung cancer, suggests a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Read the rest of this great post here
Posted in Research